Name: come to the light side: in vivo monitoring of pseudomonas aeruginosa biofilm infections in chronic wounds in a diabetic hairless murine model
Uploaded: 2017-10-10T13:00:00
Description: Watch this Scientific Journal Video about Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model Video at JoVE.co

The authors would like to thank the American Diabetes Association for supporting this work (Grant # #7-13-BS-180), the Michigan State University Research Technology Support Facility for providing training and access to the in vivo imaging system and the Michigan State University Investigative Histopathology Lab for processing the mouse biopsies for histopathological examination.

Animal experiments were approved by the Institutional Animal Care and Use Committee of Michigan State University.
1. Preparation of Occlusive Dressings and Silicone Spacers
<ol>
	<li>Cut the transparent occlusive dressing to make squares approximately 1 cm x 1 cm with scissors.</li>
	<li>Cut 10 mm circles on a 0.5 mm thick silicone sheet using a 10 mm biopsy punch.&#160;Center a 5 mm biopsy punch in the middle of the 10 mm circle and press firmly to create a hole to form a &#34;donut&#34;-li...

<ol>
	<li>James, G. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biofilms+in+chronic+wounds.">Biofilms in chronic wounds.</a> Wound Repair Regen. 16 (1), 37-44 (2008).</li><li>Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., Tobian, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+health+care+costs+of+diabetic+peripheral+neuropathy+in+the+US.">The health care costs of diabetic peripheral neuropathy in the US.</a> Diabetes Care. 26 (6), 1790-1795 (2003).</li><li>Reiber, G. E., McDonell, M. B., Schleyer, A. M., Fihn, S. D., Reda, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+comprehensive+system+for+quality+improvement+in+ambulatory+care:+assessing+the+quality+of+diabetes+care.">A comprehensive system for quality improvement in ambulatory care: assessing the quality of diabetes care.</a> Patient Educ Couns. 26 (1-3), 337-341 (1995).</li><li>Driver, V. R., Fabbi, M., Lavery, L. A., Gibbons, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+costs+of+diabetic+foot:+The+economic+case+for+the+limb+salvage+team.">The costs of diabetic foot: The economic case for the limb salvage team.</a> J Vasc Surg. 52 (Suppl 3), 17S-22S (2010).</li><li>Contag, C. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Photonic+detection+of+bacterial+pathogens+in+living+hosts.">Photonic detection of bacterial pathogens in living hosts.</a> Mol Microbiol. 18 (4), 593-603 (1995).</li><li>Rocchetta, H. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Validation+of+a+noninvasive,+real-time+imaging+technology+using+bioluminescent+Escherichia+coli+in+the+neutropenic+mouse+thigh+model+of+infection.">Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.</a> Antimicrob Agents Chemother. 45 (1), 129-137 (2001).</li><li>Kadurugamuwa, J. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+direct+method+for+monitoring+antibiotics+in+a+mouse+model+of+bacterial+biofilm+infection.">Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.</a> Antimicrob Agents Chemother. 47 (0066-4804), 3130-3137 (2003).</li><li>Anderl, J. N., Franklin, M. J., Stewart, P. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Role+of+antibiotic+penetration+limitation+in+Klebsiella+pneumoniae+biofilm+resistance+to+ampicillin+and+ciprofloxacin.">Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.</a> Antimicrob Agents Chemother. 44 (7), 1818-1824 (2000).</li><li>Morton, D. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+systematic+approach+for+establishing+humane+endpoints.">A systematic approach for establishing humane endpoints.</a> ILAR J. 41 (2), 80-86 (2000).</li><li>Dunn, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Murine+model+of+wound+healing.">Murine model of wound healing.</a> J Vis Exp. (75), e50265 (2013).</li><li>Zhao, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Delayed+wound+healing+in+diabetic+(db/db)+mice+with+Pseudomonas+aeruginosa+biofilm+challenge+-+a+model+for+the+study+of+chronic+wounds.">Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge - a model for the study of chronic wounds.</a> Wound Repair Regen. 18 (5), 467-477 (2010).</li><li>Holley, A. K., Xu, Y., Noel, T., Bakthavatchalu, V., Batinic-Haberle, I., St. Clair, D. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Manganese+superoxide+dismutase-mediated+inside-out+signaling+in+HaCaT+human+keratinocytes+and+SKH-1+mouse+skin.">Manganese superoxide dismutase-mediated inside-out signaling in HaCaT human keratinocytes and SKH-1 mouse skin.</a> Antioxid Redox Signal. 20 (15), 2347-2360 (2014).</li><li>Abbas, S., Alam, S., Pal, A., Kumar, M., Singh, D., Ansari, K. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=UVB+exposure+enhanced+benzanthrone-induced+inflammatory+responses+in+SKH-1+mouse+skin+by+activating+the+expression+of+COX-2+and+iNOS+through+MAP+kinases/NF-&#312;B/AP-1+signalling+pathways.">UVB exposure enhanced benzanthrone-induced inflammatory responses in SKH-1 mouse skin by activating the expression of COX-2 and iNOS through MAP kinases/NF-&#312;B/AP-1 signalling pathways.</a> Food Chem Toxicol. 96, 183-190 (2016).</li><li>Watters, C., Everett, J. A., Haley, C., Clinton, A., Rumbaugh, K. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Insulin+treatment+modulates+the+host+immune+system+to+enhance+Pseudomonas+aeruginosa+wound+biofilms.">Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.</a> Infect Immun. 82 (1), 92-100 (2014).</li></ol>

Here we describe a new mouse model for the study of biofilms in diabetic chronic wounds that has many advantages to create a reproducible, translatable, and flexible model.
The first innovation is the use of hairless mice. Other mouse models have been developed to study diabetic chronic wound healing10,11, but all have relied on the use of haired mice requiring the removal of fur by processes that involve either waxing or hair clipping...

Biofilms are complex communities of microorganisms embedded in a matrix of polymeric substances that have been highlighted as a contributing factor for the poor resolution of chronic wounds1. The study of these highly organized, persistent microbial populations is particularly important for diabetic patients where poor circulation on the limbs and altered peripheral sensory mechanisms lead to undetected lesions2. In the United States, it is estimated that 15% of diabetic patients will develop at least one ulcer during the course of their lives. This translates to an economic expenditure of around 28 billion dollars in treatment3,4, not to mention the immensurable emotional and social burden. Understanding the factors that allow microbial communities to persist in the wound bed and the impact these biofilms have in the healing events is imperative to drive better care for affected patients and propel the development of new treatment approaches. Therefore, the establishment of reproducible and translatable in vivo models for exploring bacterial-host interactions is paramount.
Murine models have been successfully developed to study the impact of biofilms in chronic wounds. These models, however, often utilize haired species and evaluate biofilm clearance by plate counts for viable bacterial cells of excised tissue from sacrificed animals, making them time consuming and costly.
A biophotonic alternative to the end point sampling of animals in evaluating infection was first proposed by Contag et al. (1995)5, who developed a method to capture luminescence from constitutively bioluminescent Salmonella typhimurium to measure antibiotic treatment efficacy. Other studies taking advantage of bioluminescence-emitting bacteria followed. For example, Rochetta et al. (2001)6 validated an infection model to study Escherichia coli thigh infections in mice by measuring luminescence using an intensified charge-coupled device and later, Kadurugamuwa et al. (2003)7 took advantage of the photon emitting properties of an engineered strain of Staphylococcus aureus to investigate the efficacy of several antibiotics in a catheter wound model in mice.
The method characterized here presents a straightforward protocol to induce diabetes in hairless mice, produce and inoculate wounds with pre-formed bioluminescent biofilms of P. aeruginosa, and conduct biophotonic monitoring of the infection using an in vivo imaging system. It offers a direct, rapid, in situ, non-invasive and quantitative process to evaluate biofilms in chronic wounds and in addition, allows for additional analysis such as microscopic imaging of the healing wounds, intermittent blood collection for cytokine measurements, and terminal tissue collection for histology.

<table>
	<tbody>
		<tr>
			<td>Opsite</td>
			<td>Smith &#38; Nephew</td>
			<td>Model 66000041</td>
			<td>Smith &#38; Nephew Flexfix Opsite Transparent Adhesive Film Roll 4&#34; x 11yards</td>
		</tr>
		<tr>
			<td>SKH-1 mice Crl:SKH1-Hrhr</td>
			<td>Charles River Breeding Laboratories</td>
			<td>SKH1</td>
			<td>Hairless mice, 8 weeks old</td>
		</tr>
		<tr>
			<td>Streptozotocin (STZ)</td>
			<td>Sigma Aldrich</td>
			<td>S0130-1G</td>
			<td>Streptozocin powder, 1g</td>
		</tr>
		<tr>
			<td>AccuChek glucometer</td>
			<td>Accu-Chek Roche</td>
			<td>Art No. 05046025001</td>
			<td>ACCU-CHEK CompactPlus Diabetes Monitoring Care Kit</td>
		</tr>
		<tr>
			<td>Pseudomonas aeruginosa Xen 41</td>
			<td>Perkin Elmer</td>
			<td>119229</td>
			<td>Bioluminescent Pseudomonas aeruginosa</td>
		</tr>
		<tr>
			<td>Polycarbonate membrane filters</td>
			<td>Sigma Aldrich</td>
			<td>P9199</td>
			<td>Millipore polycarbonate membrane filters with 0.2 &#956;m pore size</td>
		</tr>
		<tr>
			<td>Dulbelcco phosphate buffer saline (DPBS)</td>
			<td>Sigma Aldrich</td>
			<td>D8537</td>
			<td>PBS</td>
		</tr>
		<tr>
			<td>Tryptic soy agar</td>
			<td>Sigma Aldrich</td>
			<td>22091</td>
			<td>Culture agar</td>
		</tr>
		<tr>
			<td>Meloxicam</td>
			<td>Henry Schein Animal Health</td>
			<td>49755</td>
			<td>Eloxiject (Meloxicam) 5mg/mL, solution for injection</td>
		</tr>
		<tr>
			<td>10% povidone-iodine (Betadine)</td>
			<td>Purdue Products LP</td>
			<td>301879-OA</td>
			<td>Swabstick, Betadine Solution. Antiseptic. Individ. Wrapped, 200/case</td>
		</tr>
		<tr>
			<td>4% paraformaldehyde</td>
			<td>Fisher Scientific</td>
			<td>AAJ61899AK</td>
			<td>Alfa Aesar Paraformaldehyde, 4% in PBS</td>
		</tr>
		<tr>
			<td>Capillary glass tube</td>
			<td>Fisher Scientific</td>
			<td>22-362-566</td>
			<td>Heparinized Micro-Hematocrit Capillary Tubes</td>
		</tr>
		<tr>
			<td>Silicone to make splints</td>
			<td>Invitrogen Life Technologies Corp</td>
			<td>P-18178</td>
			<td>Press-to-Seal Silicone Sheet, 13cm x 18cm, 0.5mm thick, set of 5 sheets</td>
		</tr>
		<tr>
			<td>Tryptic soy broth</td>
			<td>Sigma Aldrich</td>
			<td>22092</td>
			<td>Culture broth</td>
		</tr>
		<tr>
			<td>IVIS Spectrum</td>
			<td>Perkin Elmer</td>
			<td>124262</td>
			<td>In vivo imaging system</td>
		</tr>
		<tr>
			<td>IVIS Spectrum Isolation chamber</td>
			<td>Perkin Elmer</td>
			<td>123997</td>
			<td>XIC-3 animal isolation chamber</td>
		</tr>
		<tr>
			<td>HEPA filter</td>
			<td>Teleflex</td>
			<td>28022</td>
			<td>Gibeck ISO-Gard HEPA Light number 28022</td>
		</tr>
		<tr>
			<td>Biopsy punches</td>
			<td>VWR International Inc</td>
			<td>21909-142</td>
			<td>Disposable Biopsy Punch, 5mm, Sterile, pack of 50.</td>
		</tr>
		<tr>
			<td>Biopsy punches</td>
			<td>VWR International Inc</td>
			<td>21909-140</td>
			<td>Disposable Biopsy Punch, 4mm, Sterile, pack of 50.</td>
		</tr>
		<tr>
			<td>Glucose</td>
			<td>J.T.Baker</td>
			<td>1916-01</td>
			<td>Dextrose, Anhydrous, Powder</td>
		</tr>
		<tr>
			<td>Citric acid</td>
			<td>Sigma Aldrich</td>
			<td>C2404-100G</td>
			<td>Citric Acid</td>
		</tr>
		<tr>
			<td>Mastisol</td>
			<td>Eloquest Healthcare</td>
			<td>HRI 0496-0523-48</td>
			<td>Mastisol Medical Liquid Adhesive 2/3 mL vial, box of 48</td>
		</tr>
		<tr>
			<td>Corning 96-well black plates</td>
			<td>Fisher Scientific</td>
			<td>07-200-567</td>
			<td>96-well clear bottom black polysterene microplates</td>
		</tr>
		<tr>
			<td>25 gauge 5/8 inch needle</td>
			<td>BD</td>
			<td>305122</td>
			<td>Regular bevel needle</td>
		</tr>
		<tr>
			<td>Bransonic M Ultrasonic Cleaning Bath</td>
			<td>Branson Ultrasonics</td>
			<td>N/A</td>
			<td>Ultrasonic Cleaner</td>
		</tr>
	</tbody>
</table>

come to the light side: in vivo monitoring of pseudomonas aeruginosa biofilm infections in chronic wounds in a diabetic hairless murine model

The presence of bacteria as structured biofilms in chronic wounds, especially in diabetic patients, is thought to prevent wound healing and resolution. Chronic mouse wounds models have been used to understand the underlying interactions between the microorganisms and the host. The models developed to date rely on the use of haired animals and terminal collection of wound tissue for determination of viable bacteria. While significant insight has been gained with these models, this experimental procedure requires a large number of animals and sampling is time consuming. We have developed a novel murine model that incorporates several optimal innovations to evaluate biofilm progression in chronic wounds: a) it utilizes hairless mice, eliminating the need for hair removal; b) applies pre-formed biofilms to the wounds allowing for the immediate evaluation of persistence and effect of these communities on host; c) monitors biofilm progression by quantifying light production by a genetically engineered bioluminescent strain of Pseudomonas aeruginosa, allowing real-time monitoring of the infection thus reducing the number of animals required per study. In this model, a single full-depth wound is produced on the back of STZ-induced diabetic hairless mice and inoculated with biofilms of the P. aeruginosa bioluminescent strain Xen 41. Light output from the wounds is recorded daily in an in vivo imaging system, allowing for in vivo and in situ rapid biofilm visualization and localization of biofilm bacteria within the wounds. This novel method is flexible as it can be used to study other microorganisms, including genetically engineered species and multi-species biofilms, and may be of special value in testing anti-biofilm strategies including antimicrobial occlusive dressings.

In developing this new model, we observed many advantages in utilizing hairless SKH-1 over C57BL/6J mice, which we have used in the past. Animals subjected to STZ injections normally experience gradual weight loss with the onset of diabetes; however, in wound healing experiments previously conducted by our laboratories reproducing the model presented by Dunn et al. (2012)9 using C57BL/6J, drastic weight loss was observed (Figure 1</str...

Watch this Scientific Journal Video about Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model Video at JoVE.co

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model Video (Video) | JoVE

Here we describe a novel diabetic murine model utilizing hairless mice for real-time, non-invasive, monitoring of biofilm wound infections of bioluminescent Pseudomonas aeruginosa. This method can be adapted to evaluate infection of other bacterial species and genetically modified microorganisms, including multi-species biofilms, and test the efficacy of antibiofilm strategies.

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model

The presence of bacteria as structured biofilms in chronic wounds, especially in diabetic patients, is thought to prevent wound healing and resolution. ...

Research

JoVE Journal

Immunology and Infection

Pseudomonas aeruginosa and Saccharomyces cerevisiae Biofilm in Flow Cells

Pseudomonas aeruginosa and Saccharomyces cerevisiae Biofilm in Flow Cells (Video) | JoVE 

Many microbial cells have the ability to form sessile microbial communities defined as biofilms that have altered physiological and pathological ...

RNA Isolation of Pseudomonas aeruginosa Colonizing the Murine Gastrointestinal Tract

RNA Isolation of Pseudomonas aeruginosa Colonizing the Murine Gastrointestinal Tract Video (Video) | JoVE

Pseudomonas aeruginosa (PA) infections result in significant morbidity and mortality in hosts with compromised immune systems, such as patients with ...

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model Video (Video) | JoVE

Graft-versus-host disease (GVHD) is the limiting barrier to the broad use of bone marrow transplant as a curative therapy for a variety of hematological ...

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung Video (Video) | JoVE

There  is growing concern about the relevance of in vitro antimicrobial  susceptibility tests when applied to isolates of P. aeruginosa from  cystic ...

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice Video (Video) | JoVE

A mouse model of chronic airway infection is a key asset in cystic fibrosis (CF) research, although there are a number of concerns regarding the model ...

Pseudomonas aeruginosa Induced Lung Injury Model

Pseudomonas aeruginosa Induced Lung Injury Model Video (Video) | JoVE

In order to study human acute lung injury and pneumonia, it is important to develop animal models to mimic various pathological features of this disease. ...

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways Video (Video) | JoVE

Studying host-pathogen interaction enables us to understand the underlying mechanisms of the pathogenicity during microbial infection. The prognosis of ...

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface Video (Video) | JoVE

The placenta shows a large degree of interspecies anatomic variability. To best understand biology and pathophysiology of the human placenta, it is ...

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model Video (Video) | JoVE

Biofilms consist of groups of bacteria encased in a self-secreted matrix. They play an important role in industrial contamination as well as in the ...

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection Video (Video) | JoVE

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of ...